Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Evaluation of a new approach for semi-automatic segmentation of the cerebellum in patients with multiple sclerosis.
The Multiple Sclerosis Performance Test (MSPT): An iPad-Based Disability Assessment Tool
Long-Term Results Underscore Value of Early MS Treatment
Treatment of human spasticity with delta 9-tetrahydrocannabinol.
ONO-4641 Met Primary Endpoint of Phase II Study in Multiple Sclerosis Patients
Reductions in neuronal peroxisomes in multiple sclerosis grey matter.
The diagnosis and management of lower urinary tract symptoms in multiple sclerosis patients.
Cognitive impairment in neuro-Behcet's disease and multiple sclerosis: a comparative study.
160 Surgical outcomes of trigeminal neuralgia in patients with multiple sclerosis.
Immune modulating peptides for the treatment and suppression of multiple sclerosis.
Bag3-Induced Autophagy Is Associated with Degradation of JCV Oncoprotein, T-Ag.
Video game training enhances cognitive control in older adults.
Riluzole inhibits the release of glutamate in the caudate nucleus of the cat in vivo.
Assessing the impact of multiple sclerosis disease activity and daclizumab HYP treatment on patient-reported outcomes: Results from the SELECT trial.
A randomized trial of stress management for the prevention of new brain lesions in MS.
The outcome spectrum of multiple sclerosis: disability, mortality, and a cluster of predictors from onset.
Frequency of Comorbidities and Their Association with Clinical Disability and Relapse in Multiple Sclerosis.
From classic to spontaneous and humanized models of multiple sclerosis: Impact on understanding pathogenesis and drug development.
Comparison of a 1.5T standard vs. 3T optimized protocols in multiple sclerosis patients.
Discovery of Biologically Active Oncologic and Immunologic Small Molecule Therapies using Zebrafish: Overview and Example of Modulation of T Cell Activation.
IFN-β therapy modulates B-cell and monocyte crosstalk via TLR7 in multiple sclerosis patients.
The role of myelin oligodendrocyte glycoprotein in autoimmune demyelination: a target for multiple sclerosis therapy?
Elevated interleukin-12 in progressive multiple sclerosis correlates with disease activity and is normalized by pulse cyclophosphamide therapy.
The role of tumour necrosis factor α in the pathogenesis of multiple sclerosis, and pentoxifylline as a possible pharmacotherapeutic intervention.
The Arabic version of the Mayo-Portland Adaptability Inventory 4: a validation study.

Pages